Niagen Bioscience (NAGE) Gross Profit (2010 - 2026)

Niagen Bioscience (NAGE) has 17 years of Gross Profit data on file, last reported at $20.0 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $20.0 million, up 3.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $83.8 million (up 24.27% YoY), and the FY2025 annual result was $83.2 million, up 35.08% from the prior year.
• Gross Profit eased to $20.0 million in Q1 2026 per NAGE's latest filing, from $21.7 million in the prior quarter.
• Over five years, Gross Profit peaked at $21.9 million in Q3 2025 and troughed at $10.0 million in Q2 2022.
• A 5-year average of $15.2 million and a median of $13.5 million in 2023 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2025: Gross Profit declined 7.1% in 2022, then soared 47.71% in 2025.
• A 5-year view of Gross Profit shows it stood at $12.0 million in 2022, then climbed by 7.66% to $12.9 million in 2023, then soared by 40.66% to $18.2 million in 2024, then rose by 19.27% to $21.7 million in 2025, then decreased by 7.96% to $20.0 million in 2026.
• Business Quant data shows NAGE's Gross Profit at $20.0 million in Q1 2026, $21.7 million in Q4 2025, and $21.9 million in Q3 2025.